Acción 6547 MEDIGEN VACCINE BIOLOGICS CORPORATION
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Medigen Vaccine Biologics Corporation

Acciones

6547

TW0006547003

Precio de cierre Taipei Exchange
Otros sitios de cotización
 00:00:00 30/04/2024 		Varia. Cinco días. Varia. 1 de enero.
51,6 TWD -0,77 % Gráfico intradía de Medigen Vaccine Biologics Corporation +4,98 % -26,39 %
15/03 Medigen Vaccine Biologics Corporation informa sobre los resultados de las ganancias para el año completo finalizado el 31 de diciembre de 2023 CI
2023 Medigen Vaccine Biologics Corporation informa sobre los resultados de las ganancias del tercer trimestre y los nueve meses finalizados el 30 de septiembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
WHO Initiative Signs New Licensing Agreements On Covid-19 Technologies [press release]
Medigen Vaccine Biologics Corporation Provides License Covid-19 Vaccine to WHO C-TAP and UN Medicines Patent Pool
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Medigen Vaccine Biologics Corporation Withdraws Covid-19 Vaccine Provisional Application and Update with Three-Dose Data for Further Review
Medigen Vaccine Biologics Corporation Approves the Election of Ming-Yi ,Wu as Independent Director and Member of Audit and Remuneration Committees
Medigen Vaccine Biologics Corporation Files New Drug Application of MVC EV71 Vaccine to Drug Administration of Vietnam
Medigen Vaccine Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Medigen Vaccine Biologics Corporation Announces Board Changes
Medigen Vaccine Biologics Corporation Announces the Resignation of Chang, Ming-Cheng as Independent Director
Medigen Vaccine Biologics Corporation Receives the NDA Approval Letter of Mvcquadrivalent Influenza Vaccine from Taiwan Food and Drug Administration
Medigen Vaccine Biologics Corporation Announces Results of MVC COVID-19 Vaccine Phase 3 Clinical Trial in Thailand
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Taiwan firm to provide free COVID-19 testing for Japan-bound visitors
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Medigen Vaccine Biologics : Clarification on media reports
Medigen Vaccine Biologics : Announcement of the company's resolutions on the stock dividend ex-rights base date
Medigen Vaccine Biologics : Announcement of the Company's full receipt of cash capital increase in 2022 and the reference date of capital increase
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 6547
  4. Noticias Medigen Vaccine Biologics Corporation
  5. Otros idiomas